Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 63629-5074

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 63629-5074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine And Naloxone Sublingual Tablets 1

Chemical structure of Buprenorphine Hydrochloride, showing its molecular configuration including aromatic rings, hydroxyl groups, and a hydrochloride (HCl) moiety.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Tablets 2

Chemical structure diagram of Buprenorphine hydrochloride dihydrate (HCl • 2H2O), showing its molecular framework including hydroxyl and ketone functional groups.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Tablets 3

An instructional illustration showing a person placing a round tablet under the tongue on the floor of the mouth. The image depicts the sublingual administration route for tablets such as Buprenorphine HCl and Naloxone HCl sublingual tablets.*

FDA Label Image

Lbl636295074

Buprenorphine/Naloxone (CIII) 8 mg/2 mg orally disintegrating tablet (ODT) packaged by Bryant Ranch Prepack in Burbank, CA. The label references a comparison to Suboxone 8 mg/2 mg tablets by Amneal Pharmaceuticals, LLC. It includes storage instructions to keep in a light-resistant container and store at room temperature 20-25°C (68-77°F). The package count is 30 tablets with NDC 6362950741.*

FDA Label Image

Lbl636297269

Buprenorphine HCl and Naloxone HCl sublingual tablet, 2 mg/0.5 mg strength, packaged by Bryant Ranch Prepack. The label indicates 30 tablets per package, with storage instructions at room temperature (20°-25°C or 68°-77°F). It is compared to Suboxone SL 2.0/0.5 mg tablets by Amneal Pharmaceuticals. The NDC number 6362972691 is displayed along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.